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THE MYCOBACTERICIDAL EFFICACY OF ORTHOPHTHALALDEHYDE AND THE COMPARATIVE RESISTANCES
OF MYCOBACTERIUM BOVIS, MYCOBACTERIUM TERRAE,
AND MYCOBACTERIUM CHELONAE
Adam W. Gregory, BS; G. Bruce Schaalje, PhD; Jonathan D. Smart, BS; Richard A. Robison, PhD

ABSTRACT
OBJECTIVES: To assess the mycobactericidal efficacy of
an agent relatively new to disinfection, ortho-phthalaldehyde
(OPA) and to compare the resistances of three Mycobacterium
species. Mycobacterium bovis (strain BCG) was compared with
Mycobacterium chelonae and Mycobacterium terrae to investigate
the feasibility of using either of the latter two species in tuberculocidal testing. M chelonae (a rapid grower) and M terrae (an intermediate grower) both grow faster and are less virulent than M
bovis (a slow grower).
DESIGN: The quantitative suspension protocol specified
by the Environmental Protection Agency (EPA), the
Tuberculocidal Activity Test Method (EPA test), was used
throughout this study. Standard suspensions of all three species
were prepared in a similar manner. Two suspensions of M bovis,
created in different laboratories, were used. These were tested
against two concentrations of alkaline glutaraldehyde to provide
reference data. Two concentrations of OPA were evaluated

against all mycobacterial test suspensions. Four replicates of
each organism-disinfectant combination were performed.
RESULTS: Results were assessed by analysis of variance. M terrae was significantly more resistant to 0.05% OPA
than either M bovis or M chelonae. At 0.21% OPA, M terrae was
slightly more susceptible than one test suspension of M bovis,
but not significantly different from the other. M chelonae was significantly less resistant than the other species at both OPA concentrations. At their respective minimum effective concentration, OPA achieved a 6-log10 reduction of M bovis in nearly one
sixth the time required by glutaraldehyde (5.5 minutes vs 32
minutes).
CONCLUSIONS: These data, along with other recent
studies, lend support to the idea that M terrae may be a suitable
test organism for use in the tuberculocidal efficacy testing of disinfectants. They also confirm the relatively rapid tuberculocidal
activity of OPA (Infect Control Hosp Epidemiol 1999;20:324-330).

While airborne transmission of tuberculosis (TB) is
the most common route of spread, cases due to indirect
contact with semicritical medical instruments (such as
bronchoscopes and endoscopes) continue to occur.1-4
Contributing to this problem are exaggerated tuberculocidal label claims, which have been discovered even on highlevel disinfectants.5-7 Worse yet, some disinfectants have
been found to support the presence of contaminating bacteria for extended periods of time.8-10 Because mycobacteria generally are more resistant to chemical disinfection
than most other vegetative organisms,11 these data raise
special concerns with respect to Mycobacterium tuberculosis. One way to reduce the incidence of disease caused by
inadequately disinfected medical devices is to assure that
tuberculocidal assessment of disinfectants is accomplished
with accurate and standardized test procedures.

One of the most critical variables in tuberculocidal
testing is the selection of the challenge organism (which
should possess resistance equivalent to that of M tuberculosis). This has been a source of variability in past studies,
contributing to the difficulty of establishing a truly standardized protocol. The quantitative suspension procedure
currently approved by the Environmental Protection
Agency (EPA) was described first in 1987 by Ascenzi et al.5
Known as the EPA Tuberculocidal Activity Test Method
(EPA test), this quantitative procedure has attempted to
control many of the variables involved in tuberculocidal
testing. It specifies the use of Mycobacterium bovis (strain
BCG) as the challenge organism.12 M bovis also is specified
in the Association of Official Analytical Chemists tuberculocidal procedure.13 It is related closely to M tuberculosis
and has demonstrated similar levels of resistance to a vari-
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ety of disinfecting agents.14 However, the use of M bovis has
drawbacks. In addition to being more virulent than several
other known strains, it is slow-growing, requiring at least 3
weeks before final results can be obtained.
Several researchers have experimented with fastergrowing, less pathogenic strains of mycobacteria in hopes
of identifying a more suitable test species. This study
involves a comparative analysis of a rapid-growing species
(Mycobacterium chelonae) and an intermediate-growing
species (Mycobacterium terrae) with M bovis (a slow-growing
species).
The comparative resistances of these strains were
evaluated using ortho-phthalaldehyde (OPA), a compound
relatively new to disinfection. The current standard for
high-level disinfection of semicritical instruments is 2% alkaline glutaraldehyde. Although this agent has well-documented
bactericidal, sporicidal, and mycobactericidal activity, it is
not without deficiencies, including inactivation by spontaneous polymerization and loss of activity with dilution.15,16 It
also requires a relatively long exposure time to exact a significant tuberculosis kill.17
Because OPA is a relatively novel disinfectant, few efficacy studies have been performed. However, the limited
available data suggest that it has much higher activity than
2% glutaraldehyde, especially with respect to its tuberculocidal and virucidal action. In this study, we evaluated the
mycobactericidal effects of two concentrations of OPA on the
three mycobacterial species. For comparison purposes, data
also were collected on two concentrations of glutaraldehyde
using the current tuberculocidal test organism, M bovis.
METHODS

Test Organisms
Stock suspensions of M terrae (American Type
Culture Collection [ATCC] 15755), M chelonae (ATCC
35752), and M bovis (ATCC 35743) were prepared according to the procedure specified in the EPA test protocol12
with the following modifications: The final scale-up was performed by adding 50 mL of culture to each of two 2-L plastic roller bottles containing 450 mL of modified ProskauerBeck medium, prepared in our laboratory, containing 0.1%
Tween 80. Cultures were incubated with loose caps at 37ºC,
rolling slowly, for various times depending on the species.
As specified in the EPA protocol, when the
absorbance of the culture at 500 nm reached a minimum of
0.6 (1⫺5⫻108 colony-forming units [CFU]/mL), the cells
were harvested. On the day prior to harvest, Tween 80 was
added to a final concentration of 0.1% in each bottle. The
suspensions were homogenized in a Teflon-on-glass tissue
grinder and frozen at ⫺70ºC, as specified.
Disinfectants
Four samples of disinfectant were used: two concentrations of alkaline gluteraldehyde (Cidex activated dialdehyde solution, Johnson & Johnson Medical, Inc, Arlington,
TX) and two concentrations of OPA (Cidex OPA solution,
Johnson & Johnson Medical, Inc). The two glutaraldehyde
solutions came from the same lot. One was freshly activated
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(2.5%), and one was stressed through simulated reuse, as
described below, and diluted to contain 1.5% glutaraldehyde.
This latter solution constitutes the manufacturer’s minimum
effective concentration. The OPA samples originated from a
solution stressed through simulated use and diluted to contain 0.21% (the minimum effective concentration) and 0.05%
OPA. The 0.05% OPA solution provided longer kill times, for
more suitable comparison of the three Mycobacterium
species. Simulated reuse of the disinfectant solutions consisted of the addition of 5% horse serum and the processing of
two sets of anesthesia equipment for 42 cycles over 14 days,
according to a standard reuse protocol. A 0.8% phenol standard, the control disinfectant solution specified in the EPA
test method, also was assayed with each test suspension.
Test Suspensions
Mycobacterial test suspensions were prepared
according to the EPA test protocol. On each test day, the
required number of frozen stock vials was allowed to thaw.
The contents of each vial were added to a prechilled 30-mL
Teflon-on-glass tissue homogenizer with an equal volume
of phosphate-buffered gelatin. The mixture was homogenized on ice for 1 to 2 minutes. The homogenized suspension then was diluted using ice-cold physiological saline
solution containing 0.1% Tween 80 to approximately 1⫻107
CFU/mL. This suspension was kept on ice until used to
inoculate test disinfectants.
Disinfectant Test Procedure
All disinfectants were assayed according to the EPA
test protocol. Each test consisted of inoculating the disinfectant at time zero with a standardized test organism suspension and sampling this mixture at predetermined time
intervals. In all cases, tubes containing 9 mL of the appropriate test disinfectant were equilibrated in a 20ºC water
bath. At time zero, a 1-mL aliquot of the prepared test suspension was added to the disinfectant and mixed by vortexing. For the tests involving glutaraldehyde, sampling
times were 2, 4, 8, and 16 minutes for the 2.5% freshly activated solution and 4, 8, 16, and 32 minutes for the 1.5% minimum effective concentration solution. In each case, 2.0-mL
samples were taken and added to 2.0 mL of a freshly prepared sodium bisulfite neutralizer. The concentration of
sodium bisulfite was 2.2 times the assayed concentration of
glutaraldehyde. For all tests involving OPA, 1-mL samples
were taken at 1, 2, 4, 8, and 16 minutes for the 0.05% solution and at 0.5, 1, 2, 4, and 8 minutes for the 0.21% solution.
Samples were added to 9-mL tubes of Letheen broth containing 1% fresh sodium bisulfite (neutralizer solution). All
remaining procedures in the testing of both disinfectants
were identical. After approximately 1 minute, serial dilutions (1:10) of neutralized samples were carried out in
physiological saline solution to a predetermined point
(dependent upon expected counts for each sample).
Phenol control evaluations of each prepared test suspension were performed as specified in the EPA test protocol. Tubes containing 9 mL of 0.8% phenol were equilibrated
in a 25ºC water bath and inoculated with 1 mL of test sus-
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pension. After 20 minutes, 1-mL samples were taken and
mixed with 9 mL of Letheen neutralizer solution. Serial dilutions (1:10) were carried out in physiological saline solution.
For all samples, selected dilution tubes (of neutralized suspensions) were assayed in duplicate for the number of viable organisms by membrane filtration. A 1-mL
aliquot of the chosen dilution was added to approximately
50 mL of physiological saline solution in a disposable plastic funnel (Microfil system, Millipore, Bedford, MA).
Standard cellulose filters (Millipore, 0.45-µm pore size, 47mm diameter) were used. After applying vacuum, filters
were washed with an additional 50 to 100 mL of physiological saline solution and placed on Middlebrook 7H11 agar
supplemented with 10% BACTO-OADC enrichment (Difco,
Detroit, MI). The agar plates were placed in 1-gallon polyethylene bags, sealed with twist ties, and incubated until
colonies could be counted readily. This was approximately
20 to 24 days for both M terrae and M bovis, and 3 to 4 days
for M chelonae. While small colonies of M terrae were counted after 14 days, plates were reincubated and assessed again
at the same time as the M bovis samples to ensure reliable
colony counts. M chelonae was incubated at 32ºC, whereas
both M terrae and M bovis were incubated at 37ºC.
Results of the individual colony counts for the various assays are available on request.
Disinfectant Neutralization Controls
For all disinfectant samples, a neutralization verification was conducted with each organism on every test day.
During the glutaraldehyde tests, this procedure consisted of
inoculating a mixture of 2 mL of disinfectant and 2 mL of neutralizer with 400 organisms in 40 µL. In the OPA tests, 100 µL
containing 1,000 organisms was added to a mixture of 1 mL
of disinfectant and 9 mL of neutralizer. This resulted in an
inoculum of approximately 100 CFU/mL in each tube. In all
cases, these suspensions were allowed to sit for at least 20
minutes prior to assay to detect any residual killing activity
from unneutralized disinfectant. They then were assayed for
viable organisms in a manner identical to the procedure
described above. The percent inhibition for each control was
determined as follows: percent inhibition (PI)=[(Expected #
of Colonies⫺Observed # of Colonies)/(Expected # of
Colonies)]⫻100. The Expected # of Colonies was obtained
from the viable count assay for each test suspension.
Statistical Methods
Data for this study were collected over a total of 12 test
days, 4 for glutaraldehyde, and 8 for OPA. Data for each disinfectant were analyzed separately. The response variable for
both analyses was the time to a 6-log10 reduction for each test
organism. The times were calculated for each replication of
every organism-disinfectant combination by linear regression of log(S/S0) versus time, where S0 is the baseline count
and S is the concentration of viable organisms at a particular
sample time. The SAS (SAS Institute, Cary, NC) procedure
REG was used for these regressions.
The 4 days of glutaraldehyde testing consisted of two
suspensions of M bovis (a and b, each prepared in different
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laboratories) exposed to two concentrations of glutaraldehyde (1.5% minimum effective concentration and 2.5%
[fresh] solution). On every test day, each M bovis suspension was tested against both concentrations of glutaraldehyde. Six-log10-reduction times were analyzed using a
mixed-effects analysis of variance model. “Technician” and
“test day” were deemed random factors, whereas “suspension” and disinfectant “concentration” were considered to
be fixed factors. The variance components associated with
the random factors were estimated using restricted maximum likelihood and were tested using an approximate Z
test. The main effects and the interaction of the fixed factors were evaluated with F statistics. All calculations were
done using the MIXED procedure of SAS.
The 8 days of testing with OPA originally were
designed as a balanced two-factor split-unit experiment,
with days as whole units. The whole-unit factor was disinfectant “concentration” (0.05% and 0.21%) and the sub-unit
factor was “organism” (M chelonae, M terrae, and M bovis).
Concentrations were assigned to days, and every organism
was tested on every day. Thus, every organism-concentration
combination was replicated four times. As in the glutaraldehyde testing, two different suspensions of M bovis (a and b)
were used. This time, one was used for the first 4 days and
the other for the last 4 days. In this analysis, it was decided
to treat these suspensions as different organisms. Therefore,
“organism” was partially a whole-unit factor and partially a
split-unit factor. Due to variance heterogeneity, the 6-log10
reduction times for each organism-concentration combination were transformed to the logarithmic scale for analysis.
Because the design was an unbalanced split-unit design,
statistical analysis was done using a maximum likelihood
analysis of variance procedure. The SAS procedure MIXED
was used for the analysis. “Test day” was treated as a random factor, whereas “organism,” “concentration,” and their
interaction were treated as fixed factors. Adjusted means,
along with their standard errors, were calculated for all
organism-concentration combinations.
These were converted back to the original scale for
presentation in figures and tables. Results expressed as
time to achieve a 6-log10 reduction are those determined by
the described statistical regression procedures and do not
necessarily represent an actual measurement at that point.
Linear contrasts were used to investigate prespecified
comparisons of means, such as the mean for M bovis versus
the mean for M terrae at each of the disinfectant concentrations. P values were adjusted for the multiplicity of contrasts examined.
RESULTS

Figure 1 shows the mean times (in minutes)
required for a 6-log10 reduction for each suspension of M
bovis tested against both concentrations of glutaraldehyde.
Table 1 shows the results of the statistical analysis of these
data. The M bovis “a” suspension was significantly more
resistant, rendering longer 6-log10 reduction times across
both glutaraldehyde concentrations. As expected, there
was a significant difference between disinfectant concen-
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FIGURE 1. Mean times required to effect a 6-log10 reduction of
Mycobacterium bovis suspensions from two different laboratories (M bovis-a
and M bovis-b). Two glutaraldehyde concentrations were tested: 2.5% fresh
solution (grey bars) and 1.5% minimum effective concentration (white bars).
The precise result is shown above each column. The bars show the standard
error of the mean.

TABLE 1
STATISTICAL ANALYSIS
Parameter

Suspension†
Concentration‡
Interaction
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FIGURE 2. Mean times required to effect a 6-log10 reduction for
Mycobacterium chelonae, Mycobacterium terrae, and Mycobacterium bovis,
using two different ortho-phthalaldehyde concentrations: 0.21% minimum
effective concentration (grey bars) and 0.05% (white bars). M bovis suspensions from two different laboratories (M bovis-a and M bovis-b) were used.
The precise result is shown above each column. The bars show the standard
error of the mean.

GLUTARALDEHYDE DATA

Variance Components Estimates*
Estimate

Technician
Test day
Error

Source

OF

OF

TABLE 2
STATISTICAL ANALYSIS

0.00
2.87
5.58

Parameter

Tests of Fixed Effects
Degrees of Freedom
Numerator Denominator F Statistic
1
1
1

8
8
8

22.9
183
1.61

OF

Test day
Error

P>F
.001
<.001
.240

* Restricted maximum likelihood.
† Suspension A or suspension B.
‡ 1.5% (minimum effective) or 2.5% (fresh).

Source
Organism†
Concentration‡
Interaction

ORTHO-PHTHALALDEHYDE DATA

Variance Components Estimates*
Estimate
0.003
0.010
Tests of Fixed Effects
Degrees of Freedom
Numerator Denominator F Statistic
3
1
1

10
6
10

54.4
869
37.9

P>F
<.001
<.001
<.001

* Restricted maximum likelihood.
† Mycobacterium bovis (A or B), Mycobacterium terrae, and Mycobacterium chelonae.
‡ 0.21% (minimum effective) or 0.05%.

trations. The 1.5% minimum effective concentration produced times approximately twice those of the 2.5% fresh
solution, across both M bovis suspensions. Variance components for “technician” and “test day” were both small.
The “suspension” by “concentration” interaction was nonsignificant, indicating that the effect of one factor on the 6log10 reduction times was not affected by a change in the
other factor. In other words, both M bovis suspensions gave
the same results relative to each of the two concentrations
of glutaraldehyde.
Figure 2 shows the mean times (in minutes)
required by each concentration of OPA to effect a 6-log10
reduction of each of the three Mycobacterium species
involved in this study. Table 2 shows the statistical analysis
of these data. The variance component for “test day” was
small. There was a significant difference between test

“organisms” used. Disinfectant “concentrations” also differed significantly in activity, as expected. The “organism”
by “concentration” interaction was also significant, indicating that the different species responded differently from
one disinfectant concentration to the other. To examine
these differences in more detail, specific contrasts were
performed. These contrasts are detailed in Table 3 and,
together with Figure 2, show the following:
1. Both M bovis suspensions (a and b) react in a similar
manner to changes in OPA concentration (Table 3, line 1).
2. M bovis and M chelonae do not react in a similar
way to changes in OPA concentration (Table 3, line 2).
3. M bovis and M terrae do not react in a similar way
to changes in OPA concentration (Table 3, line 3).
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TABLE 3
DETAILED STATISTICAL ANALYSIS
SIGNIFICANCE

OF

AND
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ORTHO-PHTHALALDEHYDE DATA: SELECTED INDIVIDUAL CONTRASTS

Parameter
Interactions with OPA concentrations
1. Mycobacterium bovis: a vs b
2. M bovis vs Mycobacterium chelonae
3. M bovis vs Mycobacterium terrae
4. M chelonae vs M terrae
Comparisons over OPA concentrations
5. M bovis: a vs b
6. M chelonae vs M terrae
0.05% OPA
7. M bovis vs M terrae
8. M bovis-a vs M terrae
9. M bovis-b vs M terrae
0.21% OPA
10. M bovis vs M terrae
11. M bovis-a vs M terrae
12. M bovis-b vs M terrae

May 1999

AND

THEIR CORRESPONDING

SE

P

0.050
0.872
1.00
⫺0.130

0.157
0.102
0.102
0.102

.755
<.001
<.001
.232

⫺0.294
⫺0.611

0.078
0.051

.004
<.001

0.693
0.559
0.827

0.072
0.091
0.091

<.001
<.001
<.001

⫺0.309
⫺0.468
⫺0.150

0.072
0.091
0.091

.002
<.001
.131

Estimate

Abbreviations: OPA, ortho-phthalaldehyde; SE, standard error.

4. M chelonae and M terrae react in a similar way to
changes in OPA concentration (Table 3, line 4).
5. When both concentrations of OPA are considered,
there is a significant difference in the resistances of the two
M bovis suspensions (Table 3, line 5).
6. When both concentrations of OPA are considered,
M terrae is significantly more resistant than M chelonae
(Table 3, line 6).
7. M terrae is significantly more resistant to 0.05%
OPA than either suspension of M bovis (Table 3, lines 7-9).
8. M terrae is significantly more susceptible to 0.21%
OPA than M bovis-“a,” but not significantly different than M
bovis-“b” (Table 3, lines 10-12).
On every test day, each organism suspension was
exposed to 0.8% phenol, as specified in the EPA protocol.
Log10 reductions were calculated for every exposure, and,
after completing all test days, mean values were determined for each organism. As shown in Figure 3, both M
chelonae and M terrae were significantly more resistant to
0.8% phenol than was M bovis.
An analysis of the percent inhibition data to confirm
neutralization efficacy indicated that all disinfectants were
neutralized completely following their specific contact period (data not shown).
DISCUSSION

The use of a standardized mycobacterial test suspension is an issue central to effective and meaningful tuberculocidal testing. Although M bovis has been the standard
for tuberculocidal testing in the United States, other
species may prove ultimately to be more suitable. Rapidgrowing, less virulent saprophytic species of mycobacteria,
such as M smegmatis, have been considered for tubercu-

locidal testing in the past, but it has since been demonstrated that such species are more susceptible to disinfection than M tuberculosis.18-21 M chelonae was included in the
present study, to evaluate the performance of a representative rapid-growing species against OPA. As expected, this
organism demonstrated significantly less resistance to
OPA than either of the other species tested. Clearly, estimates of tuberculocidal activity based on data from such
rapid-growing species are not predictive of activity against
either M bovis or clinical tuberculosis isolates.14
M terrae, an intermediate grower, may represent a
more reasonable alternative. This study showed M terrae
to be either similar or more resistant to OPA than M bovis.
Although relatively unexplored in the United States,
European researchers have shown this organism to have
resistance comparable to, or greater than, M tuberculosis.
In 1978, Sonntag conducted a comparative analysis of M
terrae and M tuberculosis against several disinfectants.22 It
was found that the two species exhibited approximately
equal resistance to aldehydes, phenols, amphotensides,
and peracetic acid. Seven years later, Sonntag and Hingst
presented a comparison of M terrae and M tuberculosis
using six different disinfectants.23 Their findings again
revealed very similar resistance profiles between the two
organisms, this time with M terrae showing slightly greater
resistance to all of the disinfectants tested. Also of possible
significance was their finding of high levels of common
membrane antigens shared by these two species. Similar
results were achieved by vanKlingeren and Pullen.24 After
finding M terrae and M tuberculosis to have similar resistance to 11 disinfectants, they recommended the use of M
terrae for quantitative suspension tuberculocidal testing. A
1998 study by Griffiths et al provided recent confirmation
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of these findings.25 They reported M terrae either to equal
or exceed M tuberculosis in resistance to six disinfectants.
In addition, the German Society for Hygiene and
Microbiology already has declared M terrae its official
tuberculocidal test species.26
Obviously, the most important consideration when
selecting an organism to assess tuberculocidal activity is the
way it behaves in relation to M tuberculosis or a similar documented standard. This study involved a comparative analysis of M chelonae and M terrae against the current EPAapproved test organism, M bovis. Previous work done in our
laboratory has shown that standard M bovis suspensions
often differ from laboratory to laboratory.7 For this reason,
two different M bovis suspensions (each prepared in different laboratories) were used. Not surprisingly, the two suspensions gave slightly different results. Nonetheless, M terrae showed similar resistance to M bovis when subjected to
a new, highly effective chemical disinfectant not evaluated in
any of the aforementioned studies. These results support the
conclusions of other researchers who have proposed using
M terrae in tuberculocidal testing of aldehydes. Along with
possessing a resistance profile similar to M tuberculosis (and
in this case, M bovis), the lower virulence and more rapid
growth of M terrae make it an attractive alternative to the
current M bovis standard. Interestingly, the resistances of M
bovis, M chelonae, and M terrae to the 0.8% phenol standard
were very different (Figure 3). M chelonae, although the
organism most sensitive to OPA, was by far the most resistant to phenol. These results raise old doubts concerning the
validity of the phenol resistance window that all M bovis suspensions used for tuberculocidal testing currently are
required to meet. They reinforce the fact that the phenol
resistance of a particular organism does not necessarily correlate with its resistance to other disinfectants.
The rapid tuberculocidal activity of OPA is a separate
important finding of this study. Although glutaraldehyde
has long been the standard for high-level disinfection
among chemical germicides, its tuberculocidal activity has
been documented to be relatively slow. In a 1995 analysis of
three glutaraldehyde-based disinfectants, Jette et al concluded that “the search for a safer, non-damaging and ‘userfriendly’ alternative to glutaraldehyde should continue as
safer more dilute solutions require long, impractical exposure times for high level disinfection.”27 A comparison of
the tuberculocidal activities of glutaraldehyde and OPA can
be made by contrasting Figures 1 and 2. At the minimum
effective concentration of 1.5%, glutaraldehyde required a
mean of 32 minutes to achieve a 6-log10 reduction of M
bovis. In contrast, OPA at its minimum effective concentration of 0.21% required a mean of only 5.5 minutes to achieve
the same level of kill, making OPA nearly six times faster
than alkaline glutaraldehyde by this measure.
OPA has been shown to have other advantages over
glutaraldehyde as a hospital-level disinfectant. In 1993, Alfa
and Sitter conducted a thorough in-hospital assessment of
the effectiveness of 0.5% OPA on bronchoscopes, gastroscopes, and colonoscopes.28 Instruments were checked for
the presence of residual bacteria, viruses, parasites, and
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FIGURE 3. Mean log10 reductions for Mycobacterium chelonae,
Mycobacterium terrae, and Mycobacterium bovis produced by exposure to
0.8% phenol at 25ºC for 20 minutes. The precise result is shown above each
column. The bars show the standard error of the mean.

fungi after a 5-minute exposure to OPA at room temperature.
Of the 100 endoscopes disinfected following use, none of
these organisms could be detected (the detection limit being
10 CFU/mL). Data from microbial load assays prior to disinfection indicated that OPA effected greater than a 5-log10
reduction of organisms (protected by extensive organic
material) within 5 minutes. They further confirmed that the
concentration of OPA remained >0.45% over the entire 14day test period for all 19 batches tested. These data are consistent with a study by Robison et al in which both 0.5% OPA
and 2% alkaline glutaraldehyde were compared in a clinicaluse crossover study involving four dental operatories.29 This
study compared the antimicrobial and clinical characteristics
of both disinfectants. OPA was found to have a significantly
higher antimicrobial activity than glutaraldehyde against M
bovis, polio virus, and Candida albicans under all phases of
clinical use. The mean tuberculocidal times of the 0.5% OPA
were roughly one tenth those of the glutaraldehyde. Even
after 3 weeks of storage and loading of the OPA solution with
10% human whole blood, its tuberculocidal activity remained
at least two times faster than that of the fresh glutaraldehyde
solution. Because OPA does not polymerize, the concentration of active ingredient did not decrease with age alone.
Also, consistent with the results of Alfa and Sitter, the detrimental effects of dilution caused by clinical use were minimal for the OPA solutions. Clinically, OPA was preferred by
most users because it was less corrosive than glutaraldehyde and had a much less objectionable odor.
In summary, this study has shown that M terrae and
M bovis have similar resistances to OPA. The rapid grower,
M chelonae, was significantly more susceptible. This,
viewed with similar studies using other disinfectants, lends
support to the consideration of M terrae as a replacement
for M bovis in tuberculocidal testing of aldehydes. In addition, this work confirms the efficacy and celerity of OPA as
a tuberculocidal disinfectant, acting with nearly six times
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the speed of glutaraldehyde at their respective minimum
effective concentrations.
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